220 related articles for article (PubMed ID: 23735826)
1. Novel synthetic acridine derivatives as potent DNA-binding and apoptosis-inducing antitumor agents.
Lang X; Li L; Chen Y; Sun Q; Wu Q; Liu F; Tan C; Liu H; Gao C; Jiang Y
Bioorg Med Chem; 2013 Jul; 21(14):4170-7. PubMed ID: 23735826
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
Zhang W; Zhang B; Zhang W; Yang T; Wang N; Gao C; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2016 Jun; 116():59-70. PubMed ID: 27060757
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
Antonini I
Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
[TBL] [Abstract][Full Text] [Related]
5. Antitumour polycyclic acridines. Part 2. Physicochemical studies on the interactions between DNA and novel polycyclic acridine derivatives.
Giménez-Arnau E; Missailidis S; Stevens MF
Anticancer Drug Des; 1998 Mar; 13(2):125-43. PubMed ID: 9524555
[TBL] [Abstract][Full Text] [Related]
6. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding.
Bouffier L; Baldeyrou B; Hildebrand MP; Lansiaux A; David-Cordonnier MH; Carrez D; Croisy A; Renaudet O; Dumy P; Demeunynck M
Bioorg Med Chem; 2006 Nov; 14(22):7520-30. PubMed ID: 16879973
[TBL] [Abstract][Full Text] [Related]
7. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
9. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
10. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
11. Influence of substituent modifications on DNA binding energetics of acridine-based anticancer agents.
Hutchins RA; Crenshaw JM; Graves DE; Denny WA
Biochemistry; 2003 Nov; 42(46):13754-61. PubMed ID: 14622022
[TBL] [Abstract][Full Text] [Related]
12. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
[TBL] [Abstract][Full Text] [Related]
13. Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.
Missailidis S; Stanslas J; Modi C; Ellis MJ; Robins RA; Laughton CA; Stevens MF
Oncol Res; 2002; 13(3):175-89. PubMed ID: 12549627
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological research of novel azaacridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
Li D; Yuan Z; Chen S; Zhang C; Song L; Gao C; Chen Y; Tan C; Jiang Y
Bioorg Med Chem; 2017 Jul; 25(13):3437-3446. PubMed ID: 28511910
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationship and biological activity of acridine derivatives as potent MDR-reversing agents.
Wang J; Luo T; Li S; Zhhang Y; Wang C; Zhao J
Curr Med Chem; 2013; 20(32):4070-9. PubMed ID: 23895691
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment.
Cui Z; Li X; Li L; Zhang B; Gao C; Chen Y; Tan C; Liu H; Xie W; Yang T; Jiang Y
Bioorg Med Chem; 2016 Jan; 24(2):261-9. PubMed ID: 26707846
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of 7-substituted-5,6-dihydrobenzo[c]acridine derivatives as new c-KIT promoter G-quadruplex binding ligands.
Guo QL; Su HF; Wang N; Liao SR; Lu YT; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2017 Apr; 130():458-471. PubMed ID: 28284084
[TBL] [Abstract][Full Text] [Related]
19. Novel synthetic 2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding antiproliferative agents.
Gao C; Liu F; Luan X; Tan C; Liu H; Xie Y; Jin Y; Jiang Y
Bioorg Med Chem; 2010 Nov; 18(21):7507-14. PubMed ID: 20863710
[TBL] [Abstract][Full Text] [Related]
20. Acridine derivatives as chemotherapeutic agents.
Denny WA
Curr Med Chem; 2002 Sep; 9(18):1655-65. PubMed ID: 12171548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
